Why the study?
Optimal therapy for PAD involves simultaneous prescription of multiple drug classes, requiring surgeons to consider drug interactions when selecting pharmacotherapy to improve patient prognosis.
What is the optimal pharmacotherapy for patients with peripheral arterial disease?
What is the optimal pharmacotherapy for patients with peripheral arterial disease?
Answers are grounded in this paper and cite their sources.
Optimal pharmacotherapy for PAD involves a combination of hypolipidemic, antithrombotic, and antihypertensive drugs, requiring careful consideration of drug interactions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
В.С. Аракелян (2021) conducted a review in Peripheral arterial disease. Pharmacotherapy (hypolipidemic, antithrombotic, antihypertensive, vasodilators) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: